This study evaluated the tumorigenesis risk of induced pluripotent stem (iPS) cells after transplantation into the cochlea. One mouse embryonic stem (ES) cell line and three mouse iPS cell lines, one derived from adult mouse tail-tip fibroblasts (TTFs) and two from mouse embryonic fibroblasts (MEFs), were neurally induced by stromal cell-inducing activity. Before transplantation, the efficiency of neural induction and the proportion of residual undifferentiated cells were evaluated using immunocytochemistry, and no significant differences were observed in the ratios of colonies expressing βIII tubulin, nestin, or octamer (Oct)3/4. Four weeks after transplantation into the cochleae of neonatal mice, the number of surviving transplants of TTFderived iPS cells generated by retroviral infection was significantly higher than those of MEF-derived iPS cells generated by plasmid transfection. Teratoma formation was identified in one of five cochleae transplanted with TTF-derived iPS cells. However, no significant differences were found in the cell proliferation activity or the extent of differentiation into mature neurons among the cell lines. These findings emphasize the necessity of selecting appropriate iPS cell lines and developing methods to eliminate undifferentiated cells after neural induction, in order to establish safe iPS cell-based therapy for the inner ear. 763 764 NISHIMURA ET AL.
INTRODUCTION
, could be of great significance. Previous studies have investigated the potential of iPS cell-based therapy for regenerative medicine in a variety of fields, Hearing loss affects millions of people worldwide and is one of the most common disabilities. Hair cells including the nervous system (16, 33, 39, 43) , which strongly suggests that they have an equivalent capacity and their associated auditory primary neurons, the spiral ganglion neurons, are essential for hearing, and defects to ES cells. We previously reported on the potential of ES cell-in these cells can result in profound hearing impairment or deafness. Recent studies have indicated the potential derived neural progenitors, which had been neurally induced by stromal cell-inducing activity (SDIA) (13), of stem cell-based approaches for the regeneration of hair cells and spiral ganglion neurons, with embryonic as transplants for the replacement of spiral ganglion neurons (17, 18, 24) . We compared the capability of iPS cell-stem (ES) cells being identified as the most promising stem cell candidate. Previously, ES cells have been used derived neural progenitors and ES cell-derived cells to differentiate into spiral ganglion neurons (23), which to generate glutamatergic neurons (30) , neurons making synaptic contacts with cochlear hair cells (17, 18) , and in suggested the possibility of substituting iPS cells for ES cells in this instance. However, iPS cells have consider-vitro hair cell-like cells (15,27), as well as in the functional recovery of transplanted cochleae in an animal able variation in their capacity for differentiation, and there is a risk of tumorigenesis among their clones model (24).
However, the use of ES cells introduces problems (19, 41) , which is a critical issue for clinical applications.
We previously used only one clone of iPS cells, and involving immune rejection and ethics. In this context, the establishment of induced pluripotent stem (iPS) did not clarify the risk for tumorigenesis after cochlear transplantation. Since then, numerous iPS clones have cells, which are generated from a patient's own cells been generated using different transcription factor com-Antibodies binations and sources (3, 21, 25, 26) . The current study
The primary antibodies used were as follows: anticompared the survival and neural differentiation capabil-βIII tubulin mouse monoclonal antibody (1:500; Covance ities, and the risk of tumorigenesis after cochlear trans-Research Products, Berkeley, CA); anti-nestin mouse plantation, among mouse ES cells and three clones of monoclonal antibody (1:500; BD Pharmingen, Franklin mouse iPS cells, which were generated using different Lakes, NJ); anti-octamer-binding transcription factor 3/4 sources and methods.
( Table  Japan ). Colonies that formed on the PA6 monolayer 1. These included three iPS cell lines, one of which was after 7 days of culture were isolated. Following fixation generated by the retroviral transduction of adult mouse with 4% paraformaldehyde in 0.1 M phosphate buffer tail-tip fibroblasts (TTFs) to produce 256H13 cells (21) for 15 min, immunostaining for βIII tubulin, nestin, and carrying the Discosoma coral red fluorescent protein octamer (Oct)3/4 against undifferentiated and differenti-(DsRed) gene driven by the cytomegalovirus early ated ES or iPS colonies was performed to test the effienhancer/chicken β-actin (CAG) promoter. The other cacy of neural induction in each cell line. Specimens two iPS cell lines were generated by the retroviral transwere viewed with a BX50 microscope (Olympus, duction of mouse embryonic fibroblasts (MEFs) to pro-Tokyo, Japan), and the number of βIII tubulin-, nestin-, duce 20D17 cells (25) , or by the plasmid transfection of or Oct3/4-positive colonies, as well as the total number MEFs to produce 440A3 cells (26). We also used the of colonies, were counted. The ratio of βIII tubulin, nesmouse ES cell line G4-2 (generously donated by Dr.
tin, or Oct3/4 expression was then calculated. Four inde-Hitoshi Niwa, Riken CDB, Kobe, Japan), which was pendent cultures were performed. derived from the E14tg2a ESC line (7) and carried the Transplantation Procedure enhanced green fluorescent protein (EGFP) gene driven by the CAG promoter (see Acknowledgments for source G4-2 ES cells and 256H13 iPS cells were genetically labeled with GFP and DsRed, respectively. Colonies that of cells). formed on the PA6 monolayer after 6 days of culture comparisons. Differences in the numbers of surviving transplants in one midmodiolus section, and in the ratio were isolated by incubation with collagenase B (Roche Diagnostics, Tokyo, Japan) for 5 min at room tempera-of expression of βIII tubulin or Ki67 in surviving transplants (G4-2, n = 2; 20D17, n = 5; 440A3, n = 4; ture. After dissociation of those isolated colonies into single cells by treatment with 0.25% trypsin-ethylenedi-256H13, n = 4) were statistically examined with onefactor factorial ANOVA, followed by Tukey-Kramer amine tetraacetic acid (EDTA) (Invitrogen) for 5 min at 37°C, 20D17 and 440A3 iPS cells were labeled with 5 test for multiple comparisons. Values of p < 0.05 were considered to be statistically significant. All data are µg/ml 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI; Invitrogen) for 5 min at room presented as the mean ± SE. temperature, and then for an additional 25 min at 4°C.
RESULTS

After labeling, cells were washed with phosphate-
Efficacy of Neural Induction Before Transplantation buffered saline (PBS) three times and resuspended at the density of 1 × 10 4 cells/µl in fresh Dulbecco/Vogt modi-The expression of nestin or βIII tubulin was observed fied Eagle's minimal essential medium. SDIA-treated in colonies derived from each cell line following SDIA cells were transplanted into C57BL/6 P3 mouse treatment ( Fig. 1a-h) , with typical filamentous struccochleae (n = 20). Animals were anesthetized using a tures of the nestin at higher magnifications ( Fig. 1a-d , combination of general anesthesia with sevoflurane and insets). The expression of Oct3/4 was found in colonies local anesthesia with 0.5% lidocaine. The left otic bulla derived from each cell line ( Fig. 1i -l). The ratios of βIII of each animal was opened to expose the round window, tubulin, nestin, or Oct3/4 expression before and after and suspensions of each cell line (4 × 10 4 cells in 4 µl SDIA treatment are shown in Figure 2 , with signifi-Dulbecco/Vogt modified Eagle's minimal essential cantly higher values of βIII tubulin and nestin expresmedium) were injected into the scala tympani through sion after SDIA treatment, indicating efficient neural the round window membrane, which was then covered induction. There were no significant differences in the with fibrin glue. ratio of nestin or βIII tubulin expression among cell lines. To identify undifferentiated cells in colonies after Fates of Transplanted Cells neural induction by SDIA, Oct3/4 expression was exam-SDIA-treated cells that had been transplanted into ined ( Fig. 1i -l) and the ratios of expression were unexneonate mouse cochleae were examined 4 weeks after pectedly high ( Fig. 2c ) after SDIA treatment, implying transplantation using immunohistochemistry. Under the presence of undifferentiated cells in colonies before general anesthesia with sevoflurane, cochleae were discell transplantation. No statistical differences in the ratio sected out and fixed with 4% paraformaldehyde for 4 h.
of Oct3/4 expression were found among cell lines. In After decalcification with 10% EDTA for 5 days, 10short, transplants derived from each cell line contained µm-thick cryostat sections were made. Midmodiolus neural-induced and undifferentiated cells in approxisections were provided for immunostaining for βIII mately similar ratios. tubulin and Ki67. At the end of the staining procedures, Fates of Transplants nuclear staining was performed with 4′,6-diamino-2phenyl-indole (DAPI). Surviving transplants were Four weeks after transplantation, surviving transplant-derived cells were found in two of the three defined as labeled cells with normal nuclear morphology, and the numbers of surviving transplants and βIII cochleae transplanted with ES cell-derived cells, five of the six transplanted with 20D17 iPS cell-derived cells, tubulin-or Ki67-positive transplants were counted in two midmodiolus sections of each cochlea. The average four of the six transplanted with 440A3 iPS cell-derived cells, and four of the five transplanted with 256H13 iPS value for each animal was used in the analysis. The ratio for the expression of βIII tubulin or Ki67 in surviving cell-derived cells ( Fig. 3a-d) . The high settlement rates of transplant-derived cells in each cell line indicate the transplants was calculated. In addition, hematoxylin and eosin (H&E) staining was performed in four randomly stability of our transplantation procedure. No significant differences in the presence of transplant-derived cells selected sections to examine tumor generation in the cochleae.
were found among the cell lines, indicating no significant difference in the capability for survival. Cochlear Statistical Analysis specimens that showed the settlement of transplantderived cells were used for further histological analyses. Differences in the ratio of expression for βIII tubulin, nestin, or Oct3/4 in the colonies before and after neural
We observed the expression of βIII tubulin in transplant-derived cells in each cell line ( Fig. 3e-h) , and the induction (n = 4 for each group) were statistically examined with two-factor factorial analysis of variance ratios of expression are shown in Table 2 . There were no significant differences in these ratios among the cell (ANOVA), followed by Bonferroni test for multiple lines, suggesting that they all have a similar ability to line-derived cells (Fig. 4 ). This tumor contained both undifferentiated cells and differentiated cells such as replace neurons in the cochlea. Ki67 expression, which is a marker of proliferating cells, was also observed in duct-forming epithelial cells, cartilage, neural cells, and mesenchymal cells (Fig. 4) . The remaining four transplant-derived cells of each cell line ( Fig. 3i-l) , indicating that the proliferative capacity of SDIA-treated cochleae transplanted with 256H13 iPS cell line-derived cells exhibited no tumor formation, similar to the cells was maintained 4 weeks after transplantation. The ratios of Ki67 expression are shown in Table 2 , and did cochleae transplanted with other cell line-derived cells. not differ significantly between the cell lines, suggesting DISCUSSION no significant difference in proliferative activity. However, there was a significant difference among the cell Here we compared the neural differentiation capability and the risk of tumorigenesis after cochlear trans-lines in the numbers of transplant-derived cells in the cochleae: the number of transplant-derived 256H13 iPS plantation among three clones of iPS cells and ES cells. Before transplantation, the efficacy of neural induction cells was significantly higher than that of 440A3 iPS cells.
Teratoma formation was identified only in one and the proportion of residual undifferentiated cells after SDIA treatment were evaluated using marker proteins cochlea that had been transplanted with 256H13 iPS cell such as nestin, βIII tubulin, and Oct3/4. SDIA was shown to induce the neural differentiation of MEF-and TTF-derived iPS cells, as well as ES cells. Unexpectedly, colonies derived from each cell line contained residual undifferentiated cells even after neural induction, indicating that transplants derived from such cell lines also contained undifferentiated cells. Presumably, some of the SDIA-treated cells may express both pluripotent and neuronal markers, in accordance with a recent study that neural precursor cells derived from human embryonic and fetal central nervous system expressed mRNA for pluripotent markers (35) . No significant differences in the ratios of marker protein expression were identified among the cell types, suggesting no apparent difference in the quality of transplants before cochlear transplantation.
Four weeks after transplantation, the majority of cochleae that had been transplanted exhibited the settlement of iPS or ES cell-derived neurons, similar to previous studies (23,24). The ratio of βIII tubulin expression in transplant-derived cells did not differ among cell lines, suggesting that all three of the iPS cell lines studied had a similar capability to ES cells for the settlement of stem cell-derived neurons in cochleae, as we observed in a previous study (23).
We investigated the proliferative activity after cochlear transplantation by immunostaining for Ki67. Interestingly, 4 weeks after transplantation, transplantderived cells with proliferation activity were present in cochleae that had undergone transplantation with all cell types, including ES cells. Moreover, no difference in the ratio of Ki67-positive cells in the transplant-derived cells was identified among the cell lines. Previous reports describing the transplantation of ES cell-derived cells into cochleae found no tumor formation (1, 2, (4) (5) (6) 8, 9, 14, 24, (28) (29) (30) 32) , suggesting that the observed proliferative activity of transplant-derived cells might not be directly associated with the risk of tumorigenesis.
By contrast, the number of transplant-derived cells in the cochleae differed among the cell lines. Although there was no significant difference between the two MEF-derived clones of iPS cells, iPS cells derived from TTFs using retrovirus gave rise to significantly higher cell numbers in transplants than iPS cells derived from cochlea, as was the case in some patients who under-cells (6, 28, 32) and fetal or adult neural stem cells (10) (11) (12) 38, 40) into cochleae was not found to result in tumor went gene therapy (22) . Another possibility is that TTFderived iPS cells have a higher risk for tumorigenesis formation. The number of cells that can be transplanted into cochleae is limited because of their tiny size, and than MEF-derived iPS cells, which is consistent with previous observations of transplantation into nonobese the numbers of settled transplant-derived cells in cochleae are reportedly low (4, 20, 34) . Therefore, the diabetic/severe combined immune deficiency (NOD/ SCID) mouse brains (19). risk for settlement of undifferentiated cells after transplantation appears to be small. Notably, teratoma forma-To our knowledge, this is the first documentation of teratoma formation in cochleae after cell transplantation. tion in the cochlea was identified after transplantation of TTF-derived iPS cells, suggesting that their use involves Previously, the transplantation of undifferentiated ES investigation is necessary to determine the risk for dated the risk for tumorigenesis of iPS cell lines following neural induction, and indicated that their origin is a tumorigenesis in the cochlea. The elimination of undifferentiated cells from transplants and/or the selection of key element for tumorigenesis, in association with the persistence of undifferentiated cells (19, 41) . The present pure progenitors must also be considered. This could be achieved by combining fluorescence-activated cell sort-finding supports this hypothesis.
Recent studies have demonstrated that iPS cells have ing with a recently reported novel method to track differentiating neural progenitors in pluripotent cultures a similar capability to ES cells for the generation of inner ear cells (23,27). These previous findings support using microRNA-regulated lentiviral vectors (31). the development of iPS cell-based therapy for inner ears, 
